The lawyer for Bidi Vapor, a disposable e-cigarette company in the United States, announced on Twitter that the United States Court of Appeals for the Eleventh Circuit has ruled in favor of Bidi Vapor and against the FDA in their legal dispute. The vote was 2-1. The court found that the FDA's marketing denial order did not take into account the restrictions on the company's marketing and sales plans and was deemed "arbitrary and capricious.
It is reported that the United States Court of Appeals for the Eleventh Circuit was established by Congress in 1981 and has jurisdiction over federal cases originating from Alabama, Florida, and Georgia. The circuit includes nine regional courts, with each state divided into north, central, and south regions.
This article is an original piece by Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use are owned by the company. Without authorization, no unit or individual may copy, reprint or use in any other way that violates the company's copyright. The company reserves the right to pursue legal responsibility against any violators.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
